• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NATERA NATERA PANORAMA NIPT TEST (NON-INVASIVE PRENATAL TEST); LABORATORY DEVELOPED TEST

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NATERA NATERA PANORAMA NIPT TEST (NON-INVASIVE PRENATAL TEST); LABORATORY DEVELOPED TEST Back to Search Results
Device Problem False Negative Result (1225)
Patient Problem Congenital Defect/Deformity (1782)
Event Date 05/09/2023
Event Type  Injury  
Event Description
False negative nipt test (non-invasive prenatal test) performed by natera.Patient was given a negative low risk result in (b)(6) of 2022, <1 in 10,000 (less than 1 in ten thousand), for trisomy 21 down syndrome.Child was born with down syndrome, (b)(6) 2023.In reality the data from the company shows they will miss 2.3% of all downs cases but they tell consumers 99.97% effective test.The company also does not reveal that the low fetal fraction <6% (less than six percent) makes the test less reliable and it should be reported to patients as such.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NATERA PANORAMA NIPT TEST (NON-INVASIVE PRENATAL TEST)
Type of Device
LABORATORY DEVELOPED TEST
Manufacturer (Section D)
NATERA
13011 mccallen pass
building a suite 100
austin TX 78753
MDR Report Key17128678
MDR Text Key317232912
Report NumberMW5118392
Device Sequence Number1
Product Code OQS
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 06/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received06/13/2023
Patient Sequence Number1
Treatment
PRENATAL VITAMINS.
Patient Outcome(s) Disability; Congenital Anomaly;
Patient Age35 YR
Patient SexFemale
Patient Weight77 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-